ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Samsung Bioepis Co., Ltd. clinical trials

Part of Samsung Epis Holdings Co., Ltd., which holds 100% as of 2025-12-31. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 33 studies whose lead sponsor is Samsung Bioepis Co., Ltd. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 29, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Samsung Bioepis with AbbVie and Astellas Pharma →

Pipeline: 4 programs

Each counted once: 4 with a study Samsung Bioepis Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2

The 4 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Samsung Bioepis Co., Ltd.’s own registered studies; Samsung Bioepis Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Samsung Bioepis Co., Ltd.’s studies test, most open studies first — 10 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of Samsung Bioepis Co., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. 1J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 33 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now26%
  • Under way, not recruiting26%
  • Completed2885%
  • Stopped early13%

Phase

  • Phase 115
  • Phase 311
  • Phase 25
  • Phase 41

Where

  • Poland14
  • Germany9
  • Korea, Republic of9
  • Czechia6
  • United States5
  • Russian Federation4

Over the years

  1. 413
  2. 14
  3. 15
  4. 16
  5. 17
  6. 18
  7. 19
  8. 20
  9. 21
  10. 22
  11. 23
  12. 24
  13. 25
  14. 426

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Samsung Bioepis Co., Ltd.

  • Samsung Bioepis Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    33 studies

Studies

Recruiting first, then most recently updated. Showing 33 of 33.